The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 29, 2020
Filed:
Mar. 29, 2017
Applicant:
Dsm Ip Assets B.v., Heerlen, NL;
Inventors:
Cyrille Deshayes, Kaiseraugst, CH;
Christine Mendrok-Edinger, Kaiseraugst, CH;
Assignee:
DSM IP ASSETS B.V., Heerlen, NL;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/107 (2006.01); A61K 31/20 (2006.01); A61K 47/08 (2006.01); A61K 8/365 (2006.01); A61K 8/37 (2006.01); A61Q 7/00 (2006.01); A61Q 19/00 (2006.01); A61K 8/49 (2006.01); A61K 8/39 (2006.01); A61K 8/86 (2006.01); A61K 8/60 (2006.01); A61K 8/06 (2006.01); A61K 8/34 (2006.01); A61K 8/35 (2006.01); A61K 8/40 (2006.01); A61K 9/00 (2006.01); A61K 47/10 (2017.01); A61K 47/14 (2017.01); A61K 47/16 (2006.01); A61Q 17/04 (2006.01);
U.S. Cl.
CPC ...
A61K 9/107 (2013.01); A61K 8/062 (2013.01); A61K 8/342 (2013.01); A61K 8/35 (2013.01); A61K 8/365 (2013.01); A61K 8/37 (2013.01); A61K 8/375 (2013.01); A61K 8/39 (2013.01); A61K 8/40 (2013.01); A61K 8/4973 (2013.01); A61K 8/602 (2013.01); A61K 8/604 (2013.01); A61K 8/608 (2013.01); A61K 8/86 (2013.01); A61K 9/0014 (2013.01); A61K 31/20 (2013.01); A61K 47/08 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61K 47/16 (2013.01); A61Q 7/00 (2013.01); A61Q 19/00 (2013.01); A61K 2800/30 (2013.01); A61K 2800/49 (2013.01); A61Q 17/04 (2013.01);
Abstract
The present invention relates to topical compositions comprising 10-hydroxystearic acid or a salt thereof and at least one nonionic emulsifier. The present invention also relates to a method to retard or inhibit the re-crystallisation of 10-hydroxystearic acid or a salt thereof in a topical composition, said method comprising formulating 10-hydroxystearic acid or a salt thereof in the presence of at least one nonionic emulsifier.